I82.4Y2 is a clinical classification representing an acute thrombotic event within the deep venous system of the left lower extremity. This code is utilized for deep vein thrombosis (DVT) involving deep veins not specifically categorized as femoral, iliac, popliteal, or tibial. In the acute phase, the thrombus is loosely attached to the vessel wall, posing a high risk of detachment and subsequent embolization to the pulmonary arteries (Pulmonary Embolism). The condition typically involves a sudden occlusion of venous return, leading to increased hydrostatic pressure and localized inflammatory response in the left leg. Clinical management focuses on rapid anticoagulation to prevent clot propagation and mechanical prophylaxis to reduce the risk of post-thrombotic syndrome.
Distinguish between acute and chronic presentations to ensure correct code selection.
Example: Patient presents with a 2-day history of acute left calf pain and swelling. Ultrasound confirms acute occlusive thrombus in the left peroneal vein. Plan: Start Enoxaparin bridge to Warfarin. Condition is acute, and laterality is clearly defined as left. This supports I82.4Y2 and risk adjustment for acute venous thromboembolism (HCC 108).
Billing Focus: Documentation must specify the episode as acute to justify the I82.4Y series versus the I82.5Y chronic series.
Specify the exact deep vein involved even when using the other specified category.
Example: Left lower extremity duplex ultrasound reveals acute thrombosis of the left peroneal and posterior tibial veins. Patient has comorbid morbid obesity and a history of smoking. The identification of specific veins like the peroneal vein, which does not have a unique fourth-character code, requires the use of I82.4Y2.
Billing Focus: Laterality (left) and the specific vein name are essential to prevent claim denials for lack of specificity.
Document the presence or absence of associated complications like pulmonary embolism.
Example: Acute embolism and thrombosis of other specified deep vein of left lower extremity (anterior tibial vein). No evidence of pulmonary embolism on CT angiography. Patient stable on Apixaban. By explicitly stating no PE, the coder can confidently use I82.4Y2 without needing additional complication codes.
Billing Focus: Clearly ruling out or ruling in complications like PE (I26 series) determines primary diagnosis hierarchy.
Report long-term anticoagulant use as a secondary code for medical necessity.
Example: Patient diagnosed with acute DVT of the left anterior tibial vein. Initiated on long-term Eliquis therapy. Current encounter includes monitoring for bleeding risks. Documenting Z79.01 alongside I82.4Y2 justifies the necessity for ongoing follow-up visits and lab monitoring.
Billing Focus: The addition of Z79.01 supports the complexity of medical decision-making for E/M leveling.
Include clinical indicators such as D-dimer results and Wells Criteria scores.
Example: Wells score of 3 (high probability). D-dimer elevated at 1200 ng/mL. Duplex ultrasound confirmed acute thrombosis in the left peroneal vein. Patient managed for acute DVT. Providing clinical evidence supports the validity of the diagnosis during payer audits.
Billing Focus: Strong clinical indicators substantiate the diagnosis code used, reducing the likelihood of medical necessity denials.
Primary diagnostic tool to confirm DVT and evaluate both legs for extent of disease.
Used for follow-up or localized assessment of the left lower extremity deep veins.
Standard code for managing an acute DVT where the physician assesses stable but acute disease and prescribes anticoagulants.
Used when the DVT is life-threatening or associated with significant comorbidities requiring complex decision-making.
Initial consultation for a new patient presenting with acute leg symptoms and confirmed DVT.
Indicated for patients with acute DVT who have contraindications to anticoagulation.
Used in severe cases of extensive deep vein thrombosis to rapidly dissolve the clot.
Required for multi-day thrombolytic protocols for extensive left leg DVT.
Used for routine follow-up where the patient is stable and therapy is unchanged.
Relevant when investigating the etiology of the acute DVT or assessing for HIT during heparin therapy.